Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target.
about
Therapeutic Hypothermia for Cardioprotection in Acute Myocardial InfarctionPhosphorylation of vasodilator-stimulated phosphoprotein (VASP) dampens hepatic ischemia-reperfusion injuryPlatelet dynamics during natural and pharmacologically induced torpor and forced hypothermiaCombined blockade of ADP receptors and PI3-kinase p110β fully prevents platelet and leukocyte activation during hypothermic extracorporeal circulationHypothermia: effects on platelet function and hemostasis.Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activitiesDelayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?Influence of temperature on thromboelastometry and platelet aggregation in cardiac arrest patients undergoing targeted temperature management.Therapeutic hypothermia in ST elevation myocardial infarction: a systematic review and meta-analysis of randomised control trials.8-BuS-ATP derivatives as specific NTPDase1 inhibitors.Antiplatelet efficacy of P2Y12 inhibitors (prasugrel, ticagrelor, clopidogrel) in patients treated with mild therapeutic hypothermia after cardiac arrest due to acute myocardial infarction.Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.Diatrack particle tracking software: review of applications and performance evaluation.Deregulation of ocular nucleotide homeostasis in patients with diabetic retinopathy.
P2860
Q26768895-83F3FCF2-987A-491C-AEC2-88A0435338D7Q27310589-F685447E-070E-44C1-BCAC-21B7D265394BQ33414555-AF24820D-B4D0-428C-AD8E-6F93CBAC1BCFQ34305447-433B98D4-AED5-4BC2-B561-0B3BAC590765Q34694417-F6A57E09-92E7-4281-A326-59220033B6ADQ36071796-7FC98216-FBDB-4D23-98F2-D6E6B9AB7697Q36183732-EB962D0F-FB37-4F7D-B7E3-1FDE6B37A319Q36779378-714CA767-DAE7-4F15-9EE6-4A6047D098ABQ36853771-686B20E3-3DE5-4F74-8861-20B955A22548Q38728771-5AC0282C-B094-4CFC-A534-5BF451CFFD67Q39989919-2C0C9887-B83B-4CD5-9B9F-49E3586ECAADQ40572790-2DF9AD12-FFC8-448F-B247-FD4DE0C232E1Q41694800-1868B5C3-1750-4434-87B2-0C95778DF339Q41930798-9396AF05-3E94-4178-995A-0C265A89C8C9Q55016047-BA1A4344-2143-40F2-85A2-4E3C5F0C23FE
P2860
Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evidence of platelet activatio ...... diator and therapeutic target.
@ast
Evidence of platelet activatio ...... diator and therapeutic target.
@en
type
label
Evidence of platelet activatio ...... diator and therapeutic target.
@ast
Evidence of platelet activatio ...... diator and therapeutic target.
@en
prefLabel
Evidence of platelet activatio ...... diator and therapeutic target.
@ast
Evidence of platelet activatio ...... diator and therapeutic target.
@en
P2093
P50
P1476
Evidence of platelet activatio ...... diator and therapeutic target.
@en
P2093
Andreas Straub
Carly Selan
Erik Westein
Hans Peter Wendel
Jan David Hohmann
Julia Kurz
Nicole Bassler
Shala Dezfouli
Stefanie Krajewski
P304
P356
10.1161/ATVBAHA.111.226373
P407
P577
2011-04-21T00:00:00Z